Internal Team vs Accelerator vs VC Fund: A Bank’s Decision Guide

Should a bank build an innovation team, join an accelerator, or invest via VC fund? A decision framework and 2025-2026 data compared.

Last updated 14 July 2026
Michèle Richner, Managing Partner, Tenity

 

Short answer:

Most banks need more than one of these models as part of their bank innovation strategy, not just one. An internal innovation team controls the roadmap but is slow to access outside technology. An accelerator partnership gives fast, low-cost access to startup deal flow but produces no equity ownership and limited control. A VC fund (direct or through a fund-of-funds) gives financial upside and market visibility but the weakest operational integration. The right choice depends on the bank’s objective: process improvement, market scanning, or financial return. Most large banks eventually run two of the three in parallel, sequenced by maturity.

Below is the comparison, the decision logic, and what current market data says about each path.

The three models at a glance

Internal innovation team Accelerator partnership VC fund investment
Primary goal Solve internal problems, build proprietary capability External market scanning, deal flow, brand presence Financial return, strategic optionality via equity
Speed to first result Slow (12-24 months to build the function) Fast (one cohort cycle, 3-6 months) Medium (fund deployment takes years to show results)
Control over roadmap Full Low, the bank does not own the startup’s direction Low, minority stakes rarely include control
Equity/IP ownership Bank owns the output Typically none to small (0-10%) Minority equity stake, no operational control
Cost profile High fixed cost (salaries, infrastructure) Lower, mostly program and staff time Variable, driven by check size and follow-on reserves
Risk profile Medium, contained to internal execution Medium, reputational and opportunity cost if poorly run High, venture-stage loss rates apply
Best measured by Pilots shipped, cost saved, process improved Partnerships signed, pipeline quality, brand credibility IRR, strategic insight, follow-on rights
Common failure mode “Innovation theatre”: activity without shipped outcomes Cohort fatigue, no follow-through after demo day Financial logic without strategic feedback loop into the bank

When an internal innovation team is the right vehicle

An internal team makes sense when the bank already knows the problem it needs to solve and the value sits in owning the solution. Examples: fraud detection models, core banking modernization, AI-driven client servicing tools that need to be deeply embedded in existing systems and data.

The tradeoff is speed and exposure. Internal teams work at the pace of the parent organization, which is built for stability, not iteration. Without a clear mandate, a defined budget, and executive sponsorship, internal innovation labs tend to drift into what practitioners call “innovation theatre”, activity that stems from an absence of clear KPIs or outdated internal processes rather than shipped outcomes. This is a structural risk, not an execution failure specific to any one bank.

When an accelerator partnership is the right vehicle

An accelerator (run in-house, outsourced to an operator, or run jointly with a platform partner) is the right tool for one specific job: external technology scanning at low commitment. It works well when the bank needs to understand what is happening at the edges of its market before deciding where to commit real capital.

What it delivers: a structured pipeline of vetted startups, direct exposure to founders solving adjacent problems, and a lower-risk way to pilot before buying, investing, or building. What it does not deliver: IP ownership, roadmap control, or exclusivity. The bank is typically one of several corporates a strong startup is talking to during and after the program.

Equity terms vary widely and are not trivial. On the well-documented end: Techstars takes a minimum 5% equity stake through a $20,000 convertible equity agreement, plus more later through an uncapped SAFE note that converts at the startup’s next priced round, Y Combinator takes 7% for its standard deal, and 500 Startups takes 5% for a $125,000 check. These are meaningful stakes, not rounding errors, and founders weigh them against the mentorship, capital, and investor access on offer.

On the other end, a smaller number of programs, MassChallenge among them, run equity-free, funded instead by corporate and government sponsors rather than by taking a piece of the startups themselves. Bank-run and corporate-partner accelerators do not always publish their exact terms, but they tend to sit within this same range rather than the much larger stakes a venture studio takes when it co-founds a company outright. Either way, the operational lift from the bank’s own team is light and programmatic compared to running an internal build team. The most common failure mode is running the program without a clear pull mechanism into the business afterward: startups graduate, demo day happens, and nothing gets procured or piloted.

When investing through a VC fund is the right vehicle

A VC fund allocation, whether a bank runs its own corporate venture capital (CVC) arm or invests as an LP in external funds, is the right tool when the primary objective is financial return and strategic optionality rather than operational integration. It is the most passive of the three models and the one with the least influence over any single startup’s roadmap.

Current market data shows this path has gotten more selective, not less relevant. Global corporate venture capital deal volume hit a seven-year low in Q1 2025, with CVCs making fewer, larger, higher-conviction bets (median deal size climbed to $10M, up from $8.9M in 2024) rather than broad portfolios. In banking specifically, the trend is sharper: total banking-sector VC deals fell to a multi-year low in Q1 2026, with funding roughly half of Q1 2025’s level, and the capital still flowing is going to companies that compete directly with banks for deposits and customer relationships, not to companies positioned as bank partners. That is a meaningful signal for any bank weighing a fund strategy: the investment thesis needs to be explicit about whether the goal is exposure to disruptive competitors, or exposure to complementary infrastructure and enabling technology. Those are different mandates and should not be run through the same fund logic.

A decision framework for bank innovation strategy

Ask three questions in this order.

1. Do you need to own the outcome, or just see it early?

If the answer must be embedded in existing infrastructure and processes, and the bank needs to own the IP, build internally. If the goal is visibility and optionality, look externally (accelerator or VC).

2. Is the objective operational (a working pilot) or financial (a return)?

Operational objectives point toward an internal team or an accelerator with a defined procurement pathway. Financial objectives point toward VC fund exposure, direct or via LP commitments.

3. What is the bank’s actual risk appetite and time horizon?

Internal teams carry medium risk over a long horizon. Accelerators carry medium risk over a short horizon with high volume. VC investing carries high risk (venture-stage loss rates) over a long horizon (funds typically run 8-10 years) in exchange for asymmetric upside.

A bank rarely lands on a single answer across all three questions. That is why most large institutions run a combination: an accelerator or scouting function to build pipeline and market intelligence, paired with either an internal build capability, a CVC arm, or both, structured as complementary rather than competing functions with a clear handover process between them. Peer-reviewed research comparing corporate venture capital and venture clienting finds that strategic renewal potential is maximized when the two are configured as complements rather than substitutes, with structured handover mechanisms between exploration and exploitation reducing friction and accelerating time to impact.

What this looks like in practice

Banks running mature innovation strategies typically separate the three functions by job, not by prestige:

Scouting and market intelligence: an accelerator, scouting program, or ecosystem platform partnership. Low cost, high volume, no ownership expected.

Build and integration: an internal lab or product team with a defined mandate tied to specific business unit problems, not a generic “explore emerging technology” brief.

Financial exposure and long-term optionality: a CVC arm or LP commitments to external funds, run with an explicit thesis (competitive intelligence vs. complementary infrastructure) and separate from the scouting function’s KPIs.

The mistake to avoid is treating these as competing options to choose between once. They answer different questions, on different timelines, with different success metrics. Picking one and expecting it to do the job of all three is the most common structural error in bank innovation strategy.

Frequently Asked Questions

Is a corporate accelerator the same as a corporate venture capital fund?

No. An accelerator runs fixed-term cohorts of startups through mentorship and programming, usually for small or no equity, with the goal of market scanning and relationship building. A CVC fund makes direct equity investments in startups, usually as a minority investor, with the goal of financial return and strategic optionality. Some corporates run both, and increasingly link them, using the accelerator as a scouting function that feeds deal flow into the fund.

Why are banks pulling back on VC investing in 2025 and 2026?

Data through Q1 2026 shows banking-sector VC funding at a multi-year low, with deal volume down and capital concentrating in fewer, larger, more mature deals. This mirrors the broader corporate venture capital market, which saw deal volume hit a seven-year low in Q1 2025 even as median deal size increased. The pattern reflects tighter conviction requirements across venture generally, not a retreat from innovation strategy as a whole.

Can a bank run an internal innovation team and an accelerator partnership at the same time?

Yes, and most large banks do. The two functions are complementary: the accelerator brings in outside deal flow and market signal, and the internal team builds and integrates what is worth keeping. The risk is coordination, not overlap. Without clear ownership of the handover point between scouting and building, the two functions compete for the same executive attention and budget instead of reinforcing each other.

What is the biggest risk of building an internal innovation lab?

Innovation theatre: activity that looks like innovation (hackathons, workshops, demo days) without a defined KPI structure or a path to shipped outcomes. This tends to happen when the internal team lacks a specific mandate tied to a business problem, or when internal processes have not been adapted to let the team move at startup speed.

Should a bank invest directly in startups or through a VC fund as a limited partner?

Direct investment (CVC) gives more visibility into individual companies and stronger signaling in the market, but requires in-house investment expertise and a longer institutional commitment. LP investing gives diversified exposure and access to top-tier fund managers with less operational overhead, but weaker direct strategic insight. Banks with a clear strategic thesis and the resources to run an investment team tend toward direct CVC; banks that want financial exposure without building that capability tend toward LP commitments.